Akers Biosciences Share Discussion Threads

[21trader] 18/8/2015 07:54

I'd say not good results there

[norbus] 17/8/2015 13:55

Have Dr Walt and Sepp Blatter ever been seen in the same place at the same time I wonder.....
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,

Only when Clinton is about; h did have a photo of some celebrity in his office and it could have been Clinton; perhaps they share a taste in goats and kids

[algernon2] 15/8/2015 18:17

A small inconsequential mention in Investors Chronicle this week.
Will you be on the phone on Tuesday Mcmather?

[algernon2] 14/8/2015 10:26

As you say a bit too much of "postponing" going on at the moment with this Company.

[mcmather] 14/8/2015 08:31

Norbus, my understanding is that nicoRette could be a bit "patchy". That there was the underlying sense of a "fag".

Thomas NicoLette however......aye, always found him a decent enough chap in my dealings with him. Gained the impression that he was keen to progress the company. Dr Walt's interest has always struck me as being self-serving.

Re securing the services of senior personnel to assist you before then jettisoning them when they, perhaps, get too close to the truth. Have Dr Walt and Sepp Blatter ever been seen in the same place at the same time I wonder.....

[mcmather] 14/8/2015 08:21

Arf. Guffaw. What's gone on here? Has Dr Walt's 'magic' pen run out? Does he read this board? Does his claimed mate Mr Clinton?

Whatever, I very much suspect that there will now be even more attention to the - for whatever reason - delayed results.

[norbus] 13/8/2015 15:18

Raymond Akers is not getting any younger; The goat he kept for antibodies died at least 5 years ago. AKR lost a good man in Thomas Nicorette

[vancoillie] 13/8/2015 10:22

Roche buy Geneweave, a rapid diagnostic test maker, for 190 mil dollar. Lot of interest in rapid diagnostic. Look to biocartis, surge on the news. Hopefully Akers Biosciences can make their test soon more digital. The tests look so old

[mcmather] 12/8/2015 22:04

Not sure what happened here / or where this came from re the date of the results?

Akers Biosciences Inc is expected to report second-quarter 2015 earnings results on Aug 11. The company had posted lackluster first-quarter results, wherein loss of 26 cents per share widened from a loss of 14 cents per share incurred in the year-ago quarter, because of declining revenues.


The Heparin range of devices is, and has been for years, the company's best seller. Since the IPO in 2014 Dr Raymond Akers has been talking this up continually in terms of new strategies, new teams, new sales VPs, etc. Investors - and particularly now in the US judging by the recent downgrade - will be watching to see what Dr Walt delivers. Or does not deliver.

It may be nothing but 3 high ranking personnel / board members have now left Dr Walt within the space of 18 months whilst the recent AGM had to be adjourned due to a lack of interest.....

[algernon2] 06/8/2015 08:10

Glad to hear it.
And another fine day has dawned and I am off to work now to earn my meagre pittance.
I am relying on Dr Akers amongst a few select others to eventually raise me from the poverty to which I am reluctantly and resentfully becoming accustomed.
Go Akers Go!!!
==
Might be nice to hear an update on their heart attack test progress.

[algernon2] 05/8/2015 23:11

I'm glad you're still here at least Mcmather; it feels lonely and quiet often on some threads.

[mcmather] 05/8/2015 22:58

From Q1 2015 results:

Additionally, a receivable of $864,000 is due on June 25, 2015......

The Company’s new distributor in Australia, et al, "36S”, placed their first order for one of the Company’s REA based products during the three months ended June 30, 2014. The Company with the assistance of 36S, has submitted the product to Australia’s Therapeutic Goods Administration and is awaiting final government approval for 36S to begin marketing the product. Although 36S has the right to return this product should the TGA deny government approval, the Company believes the likelihood of rejection is minimal and therefore recognized the entire sales transaction of $864,000 in revenue during the three months ended June 30, 2014......

The Company believes that the receivable is fully collectable and therefore no allowance for doubtful accounts is deemed necessary.....

On June 30, 2014, the Company recorded a sale of $864,000 to "36S” and Note 4). Gavin Moran, a member of the Company’s Board of Directors, has beneficial ownership in 36S.

Trade receivables – related party as of March 31, 2015 and December 31, 2014 are amounts due from 36S of $864,000.

From the AGM RNS:
As notified on June 5, 2015, Gavin Moran did not stand for re-election at the AGM and therefore his appointment as a non-executive director of the Company has ceased.

Surely not another of Dr Raymond Akers Jnr now you see it, now you don't tricks??

9 January 2015 - Greedy incompetents or citizens the US should be rightly proud of? Discussion welcome on the thread. A proclaimed mate of Mr Clinton, apparently.

[mcmather] 05/8/2015 22:44

Depends whether you are including the below in the "us" bit?

9 January 2015 - For services rendered and to be rendered to the Company the following receive:
Raymond F. Akers Jr 70,000 shares = $262,500 (based on a share price of $3.75)
Thomas J. Knox 50,000 shares = $187,500 (based on a share price of $3.75)
Gavin Moran 35,000 shares = $131,250 (based on a share price of $3.75)
Brandon Thomas Knox 25,000 shares = $93,750 (based on a share price of $3.75)

Raymond F. Akers Jr., Ph.D. Total Calculated Compensation $381,473 As of Fiscal Year 2013


Good luck wolfie and waylander by the way.

[algernon2] 05/8/2015 21:59

Christmas is coming and Raymond has not yet made us rich.

[mcmather] 21/7/2015 23:42

Some posts on here which might be of some interest:

[waylander2] 17/7/2015 09:41

Have to say after many years, I am out some months ago. This was becoming more a bad habit than an investment for me. Thanks for the tips Werewolfie, I will be taking a look at your suggestions.

Thanks all, its been.... well interesting!

Hope this comes off for you.

[werewolfie] 17/7/2015 00:05

I'm glad I'm out. You seriously need to think about it yourself McM.

Since selling Akers , Ive invested in the following -

AGA Rangemaster - i bought in at 1.18 , now sitting at 1.83 after Middleby has announced they are buying them

Quantum Pharma - bought 1.29 now sitting at 1.58. They have just taken over a smaller company called NuOharm group and i expect the share price to rise further

Optimal Payments - Mobile payments company. Genuine growth industry and it wont take 25 years either. They are awaiting the go ahead to buy a company called Skrill. If approved they will be promoted to the FTSE 250 where the fund managers will start to take real notice.

Poundland - A company which has grown substantially in 25 years of existence unlike Dr W and the Diddymen. Recently applied to takeover Christies 99p stores.

Food for thought mate

[mcmather] 16/7/2015 23:34

This from around 2008/09:

Rep. Rob Andrews (NJ-1) requests $20,000,000 for: Akers Biosciences Inc. 201 Grove Road Thorofare, NJ 08086.


This from 30 June 2015:
In addition, Mr. Andrews was appointed to the Company's Governance and Nominating Committee, Compensation Committee and Audit Committee; and will serve as the Chairman of the Company's Compensation Committee.

Anyone guess where this is going??

This from the heading:

9 January 2015 - Greedy incompetents or citizens the US should be rightly proud of? Discussion welcome on the thread.
23 July 2013 - Dr Raymond Akers disposes of 7m shares; roughly £140,000.
8 August 2013 - Proposed Nasdaq listing.
18 November 2013 - Share consolidation; 156/1.
23 January 2014 - Listing opens on Nasdaq.
14 May 2014 - Q1 2014 results - Net loss $595,600 mainly due to costs associated with NASDAQ IPO.
12 August 2014 - Q2 2014 results - Net loss $494,995 Three factors contributed to the increased loss: maintaining dual listings of our stock has significantly increased costs associated with compliance with regulatory requirements, the expansion of sales and marketing efforts and stock option based compensation for our directors, officers and key employees.
13 November 2014 - Q3 2014 results - Net loss $1,124,320 as a result of hiring additional personnel, capital market commitments and marketing activities.

9 January 2015 - For services rendered and to be rendered to the Company the following receive:
Raymond F. Akers Jr 70,000 shares = $262,500 (based on a share price of $3.75)
Thomas J. Knox 50,000 shares = $187,500 (based on a share price of $3.75)
Gavin Moran 35,000 shares = $131,250 (based on a share price of $3.75)
Brandon Thomas Knox 25,000 shares = $93,750 (based on a share price of $3.75)

Raymond F. Akers Jr., Ph.D. Total Calculated Compensation $381,473 As of Fiscal Year 2013

[algernon2] 11/7/2015 18:52

Friday:
Up 9.51% on the Nasdaq.

[algernon2] 04/7/2015 17:19

All quiet on the Western Front.

A postponed AGM due to lack of Interest.

Whither next?